Multiomic Health
Health Care · Precision Medicine

Multiomic Health news and milestones

Multiomic Health: 20 headlines on record, 7 headlines in the last 90 days. Its story counts 12 milestones.

Data updated Nov 17, 2026 · Back to the company report
20Headlines
7In 90 days
12Milestones

Headlines

Sep 232026
Blog
PRIVACY NOTICE & COOKIE POLICY who we are MultiOmic Health Limited, a private limited company registered in England and Wales (CRN: 13246608). Our registered office is located at…
Sep 232026
Blog
We are excited to announce our feature in the most recent edition of Nature Portfolio's Biopharma Dealmakers discussing the advances in AI-driven drug development.
Sep 232026
Blog
An Expert View from Henrietta Bull, science and partnership analyst, and Robert Thong, chief executive, MultiOmic Health.
Sep 232026
Blog
In this article, we look at how Mesh Bio and MultiOmic Health use AI to transform and improve the lives of metabolic syndrome patients through patient stratification and precisio…
Sep 232026
Blog
MultiOmic Health and Mesh Bio announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease.
Sep 232026
Podcast
In this week's episode of The Pharma Letter Podcast, MultiOmic chief executive Robert Thong discusses his firm's progress and ambitions for the future.
Sep 232026
Award
MultiOmic is proud to announce winning first place in the pitch competition at BIA's TechBio UK Conference 2022
Sep 4, 20252025
Blog
MultiOmic Health and BIO4 Campus announced the signing of a Memorandum of Understanding (MoU) to explore collaborative opportunities in biomedicine, biotechnology, and bioinforma…
May 30, 20252025
Blog
MultiOmic Health is using a data-driven AI-enabled approach to develop tailored therapeutics for specific subpopulations of patients with metabolic syndrome-related conditions, w…
Apr 4, 20252025
News · pharmabiz.com
MultiOmic Health inks MoU with Alloy Therapeutics to discover and develop renal tissue-targeting drugs
Apr 2, 20252025
Blog
The collaboration provides external validation of MultiOmic Health's AI-enabled precision medicine discovery platform and innovative renal therapeutic programs
Apr 1, 20252025
News · bioworld.com
Multiomic Health Ltd. and Alloy Therapeutics Inc. have signed a memorandum of understanding to jointly discover and develop first-in-class renal tissue-targeting drugs. Precision…
Dec 20, 20242024
Blog
Watch our CEO Robert Thong talk about how we are advancing precision medicine for metabolic-syndrome-related conditions at the LSX Investival Showcase in London.
Nov 15, 20242024
Blog
Selvedge Venture invests into founders and start ups with a mission to allieviate the titanic healthcare burden caused by age-related medical conditions. We invest into Pre-Seed,…
Nov 12, 20242024
Blog
MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifyi…
May 8, 20242024
Blog
We're thrilled to announce our participation at #BioEquityEurope 2024! Robert Thong, our CEO at MultiOmic Health, will be presenting on our innovative approach to tackle cardiore…
Mar 14, 20242024
Blog
Innovative multi-omics approaches to improve detection, diagnosis and prognosis of medical conditions and complications arising from metabolic syndrome Exciting PhD opportunity f…
Feb 7, 20242024
Blog
MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, is embarking on a collaborative project with the Centre for Public Health at Queen's University…
May 4, 20232023
Press release · businesswire
MultiOmic Health has closed a £5 million seed extension round to build its precision therapeutics discovery platform for metabolic syndrome
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

Multiomic Health, News. Alion, Nov 17, 2026. https://alion.io/company/multiomic/news

.json · .md · CC BY-SA 4.0